California Resources Corporation

California Resources Corporation

41.54
EUR
-1.16
(-2.72%)
-1.22EPS
Mar 08Next Earn
California Resources Corporation
HAN:1CLD
(Hannover Stock Exchange)

Recent

price

41.54

P/E

ratio

- -

div

yld

3.39%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
10.18
82.45
86.72
109.37
59.27
43.39
49.32
64.62
54.96
- -
30.88
42.85
40.42
37.29
39.11
- -
Revenue per Share
2.51
14.15
17.59
-37.54
-92.79
6.91
-6.26
6.77
-0.57
- -
7.46
6.94
8.1
4.74
4.17
- -
Basic EPS, GAAP
6.35
45
50.12
62.07
10.52
3.22
5.84
9.73
13.8
- -
8.05
9.14
9.38
7.69
9.94
- -
Free Cash Flow per Basic Share
- -
- -
- -
165.84
0.31
- -
- -
- -
- -
- -
0.17
0.78
1.16
1.42
1.56
1.22
Dividend per Share
- -
255.68
259.02
67.71
-23.6
-13.09
-18.97
-7.42
-7.91
13.66
21.29
25.91
32.3
38.84
41.4
- -
Book Value per Share
- -
255.68
259.02
67.71
-23.6
-13.09
-18.97
-7.42
-7.91
13.66
21.29
25.91
32.3
38.84
41.4
- -
Tangible Book Value per Share
387
49
49
38
38
40
43
47
49
83
82
76
70
79
87
88
Basic Weighted Avg Shares
3,938
4,073
4,284
4,178
2,270
1,753
2,096
3,063
2,693
- -
2,532
3,235
2,813
2,957
3,403
- -
Sales/Revenue/Turnover
41.67
29.71
33.78
25.32
-18.63
-4.96
7.78
25.07
18.12
- -
33.18
39.66
28.4
13.93
12.99
- -
Operating Margin (%)
675
926
1,144
1,198
1,004
559
544
502
471
- -
213
198
225
388
511
- -
Depreciation Expense
971
699
869
-1,434
-3,554
279
-266
328
-28
- -
612
524
564
376
363
- -
Net Income, GAAP
40.83
40.81
39.94
- -
- -
- -
- -
- -
1
- -
- -
31.14
24.6
27.13
27.69
- -
Effective Tax Rate (%)
24.66
17.16
20.28
-34.32
-156.56
15.92
-12.69
10.71
-1.04
- -
24.17
16.2
20.05
12.72
10.67
- -
Profit Margin (%)
- -
-306
-435
-221
-167
-301
-249
33
-218
-144
-101
-30
313
44
-112
- -
Working Capital
- -
- -
- -
6,360
6,043
5,168
5,306
5,251
5,061
632
626
644
595
1,208
1,344
- -
LT Debt
- -
9,860
9,989
2,611
-916
-557
-720
509
506
1,182
1,688
1,864
2,219
3,538
3,674
- -
Total Equity
- -
- -
8.76
- -
- -
- -
- -
14.63
7.35
- -
- -
22.76
22.39
11.67
8.65
- -
Return on Invested Capital (%)
- -
- -
8.76
- -
- -
- -
- -
11.71
3.91
- -
- -
23.11
22.64
11.58
8.98
- -
Return on Capital (%)
- -
- -
8.76
-22.76
- -
- -
- -
- -
- -
- -
43.31
29.5
27.63
13.06
10.07
- -
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
13
- -
- -
LT Borrowings
1,310
- -
- -
LT Finance Leases
55
53
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
89
89
88
Market Capitalization
- -
- -
- -

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
788
697
- -
Cash, Cash Equivalents & STI
40
56
- -
Accounts Receivable, Net
454
342
- -
Inventories
107
111
- -
Total Current Liabilities
1,441
180
- -
Payables & Accruals
705
- -
- -
ST Debt
13
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.8%
27.11%
3.84%
Free Cash Flow
- -
- -
41.8%
Net Income, GAAP
- -
- -
-3.46%
Sales/Revenue/Turnover
- -
- -
15.08%
Total Cash Common Dividend
- -
- -
20.35%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
518
509
997
924
2,957
2025
906
821
878
798
3,403
2026
967
1,092
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.14
0.12
3.86
0.36
4.74
2025
1.27
1.93
0.76
0.14
4.17
2026
-8.02
5.79
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.36
0.32
0.38
0.4
1.42
2025
0.4
0.39
0.38
0.39
1.56
2026
0.43
0.41
- -
- -
- -
Business
California Resources Corporation (CRC) is an independent energy company engaged in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids primarily in California. The company operates across key segments including exploration and production, low carbon solutions, and energy transition initiatives, offering crude oil, natural gas, and CO2 sequestration services; it focuses on conventional and unconventional reservoirs in onshore and offshore assets such as the Elk Hills Oil Field, Wilmington Oil Field, and Ventura Basin. CRC targets industrial and commercial customers in the energy sector, with operations concentrated in California and select U.S. regions, headquartered in Long Beach, California, since its founding in 2014 following the spin-off from Occidental Petroleum Corporation. Core products and services encompass upstream oil and gas production from mature fields using enhanced oil recovery techniques like steam flooding and waterflooding; natural gas processing and marketing; and low carbon mineral and energy solutions including carbon capture, utilization, and storage (CCUS) projects aimed at net-zero emissions goals. The company manages a portfolio of high-quality assets covering approximately 2.4 million net acres, producing around 150,000 barrels of oil equivalent per day, with brands and technologies centered on proprietary extraction methods and renewable natural gas development. CRC also provides midstream services for transportation and storage, serving refineries, utilities, and export markets along the U.S. West Coast. In recent developments, CRC completed the acquisition of the remaining 50.1% interest in Aera Energy LLC in October 2024, significantly expanding its asset base and production capacity to over 180,000 barrels of oil equivalent per day; this strategic move followed an initial joint venture and enhanced CRC's position as California's largest oil producer. The company launched its $1 billion Salt Creek CCUS project in 2025, marking a major expansion into carbon management with capacity for 4.5 million metric tons of CO2 storage annually, supported by partnerships with ExxonMobil and Calpine. Additionally, CRC secured a $500 million sustainability-linked financing round in early 2025 and announced plans to divest non-core assets to fund energy transition efforts, reflecting a shift toward integrated low-carbon operations amid regulatory changes in California.

Company News

  • Dividend Announcements: October 31-November 6, 2026 (Part 1 Of 2)

  • California Resources Corporation (CRC) Q3 2026 Earnings Call Transcript

  • What California Resources (CRC) Said on Its Q3 Earnings Call

  • Bloom Energy Rallies 11% on Barclays Upgrade and California Resources Tie-Up; FuelCell Energy Gains 5%, GE Vernova Climbs 3%

  • What's Going On With Bloom Energy Shares Tuesday?

  • California Resources Corporation (CRC) Q3 Earnings and Revenues Beat Estimates

  • California Resources Corporation Reports Third Quarter 2026 Financial and Operating Results

  • Carbon TerraVault Provides Third Quarter 2026 Update

  • California Resources Corporation Announces Strategic Collaboration with Bloom Energy to Advance Decarbonized Power Across California

  • Analysts Estimate California Resources Corporation (CRC) to Report a Decline in Earnings: What to Look Out for

  • Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer

  • Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

  • Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer

  • Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026

  • Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium

  • Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option

  • /C O R R E C T I O N - AbbVie/

  • Incyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026

  • AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

  • ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology